Cargando…
Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine
COVID-19 pandemic has been managed through global vaccination programs. However, the antibody waning in various types of vaccines came to notice. Hereby, PastoCovac Plus as a protein subunit vaccine was investigated in immunized health care workers by COVAXIN (BBV152). The booster vaccine was recomm...
Autores principales: | Farahmand, Behrokh, Sadat Larijani, Mona, Fotouhi, Fatemeh, Biglari, Alireza, Sorouri, Rahim, Bagheri Amiri, Fahimeh, Eslamifar, Ali, Jalali, Tahmineh, Salehi-Vaziri, Mostafa, Banifazl, Mohammad, Dahmardeh, Sarah, Eshratkhah Mohammadnejad, Azita, Bavand, Anahita, Tavakoli, Mahsa, Verez-Bencomo, Vicente, Mostafavi, Ehsan, Noori Daloii, Hassan, Ashrafian, Fatemeh, Saberpour, Masoumeh, Ramezani, Amitis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551543/ https://www.ncbi.nlm.nih.gov/pubmed/37810803 http://dx.doi.org/10.1016/j.heliyon.2023.e20555 |
Ejemplares similares
-
PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals
por: Ramezani, Amitis, et al.
Publicado: (2023) -
Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals
por: Eybpoosh, Sana, et al.
Publicado: (2023) -
A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports
por: Sadat Larijani, Mona, et al.
Publicado: (2023) -
Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (RBD)-Tetanus Toxoid (TT) Conjugated SARS-CoV-2 Vaccine (PastoCovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; A Prospective, Open-Label Clinical Trial
por: Barkhordar, Maryam, et al.
Publicado: (2023) -
No evidence for occult HBV infection in hepatitis B vaccine non-responders
por: Aghasadeghi, Mohammad Reza, et al.
Publicado: (2014)